Patent · US Active

Pharmaceutical composition containing botulinum neurotoxin

US11534394B2 · kind B2 · utility

0Cited by

4References

8Claims

0Family size

Assignee

IPSEN BIOPHARM LIMITED · GB

Inventors

Paul Webb · Leeds, GB
Mary White · Lake Jackson, US
Julie Partington · Wrexham, GB

Key dates

Filing date	Jan 5, 2020
Grant date	Dec 27, 2022
Priority date	—
Expiry date	Dec 26, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Method for treating a disease, condition, or syndrome in a subject comprising administering, to a subject in need thereof, a solid or liquid pharmaceutical composition comprising:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.